Evaluation of [68Ga]Ga-PSMA PET/CT for therapy response assessment of [177Lu]Lu-PSMA radioligand therapy in metastasized castration refractory prostate cancer and correlation with survival-Reference-Cited by-同舟云学术

Evaluation of [68Ga]Ga-PSMA PET/CT for therapy response assessment of [177Lu]Lu-PSMA radioligand therapy in metastasized castration refractory prostate cancer and correlation with survival

Published:2021-05-19 Issue:11 Volume:42 Page:1217-1226
ISSN:0143-3636
Container-title:Nuclear Medicine Communications
language:en
Short-container-title:

Author:

Kurth Jens,Kretzschmar Justus,Aladwan Hamzeh,Heuschkel Martin,Gummesson Anja,Bergner Carina,Kundt Günther,Hakenberg Oliver W.,Krause Bernd J.,Schwarzenböck Sarah M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference45 articles.

1. Chemotherapy-based treatment for castration-resistant prostate cancer.;Seruga;J Clin Oncol,2011

2. Abiraterone and increased survival in metastatic prostate cancer.;de Bono;N Engl J Med,2011

3. Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study.;Scher;Lancet,2010

4. Alpha emitter radium-223 and survival in metastatic prostate cancer.;Parker;N Engl J Med,2013

5. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.;Petrylak;N Engl J Med,2004

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the Heterogeneity of Response of [68Ga] Ga-PSMA-11 PET/CT Lesions in Patients With Biochemical Recurrence of Prostate Cancer;Clinical Genitourinary Cancer;2024-10

2. Treatment Response Imaging in Prostate Cancer;PET Clinics;2024-07

3. 177Lu-PSMA therapy in metastatic prostate cancer: An updated review of prognostic and predictive biomarkers;Cancer Treatment Reviews;2024-04

4. Change in total lesion PSMA (TLP) during [177Lu]Lu-PSMA-617 radioligand therapy predicts overall survival in patients with mCRPC: monocentric evaluation of a prospective registry;European Journal of Nuclear Medicine and Molecular Imaging;2023-10-27

5. Diagnostic Performance of 68Ga-PSMA-11 Positron Emission Tomography/Computed Tomography to Monitor Treatment Response in Patients with Metastatic Prostate Cancer: The Concordance Between Biochemical Response and Prostate-specific Membrane Antigen Results;European Urology Focus;2023-09